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Abstract
Nerve injuries causing segmental loss require nerve grafting. However, autografts and allografts have limitations for clinical
use. Peripheral nerve xenotransplantation has become an area of great interest in clinical surgery research as an alternative
graft strategy. However, xenotransplant rejection is severe with cellular immunity, and Th1 cells play an important role in
the process. To better understand the process of rejection, we used peripheral nerve xenografts from rats to mice and found
that mononuclear cells expressing IFN-c and IL-17 infiltrated around the grafts, and IFN-c and IL-17 producing CD4+ and
CD8+ T cells increased during the process of acute rejection. The changes of IL-4 level had no significant difference between
xenotransplanted group and sham control group. The rejection of xenograft was significantly prevented after the treatment
of IL-17 and IFN-c neutralizing antibodies. These data suggest that Th17 cells contribute to the acute rejection process of
peripheral nerve xenotransplant in addition to Th1 cells.
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Introduction
Peripheral nerve injuries are very commonly seen in the clinic.
If they cannot be immediately repaired to recover continuity and
integrity, they often result in motor and sensory deficits for patients
[1]. In many instances these injuries result in long nerve segment
loss preventing the nerve ends from being directly sutured due to
increased tension [2]. In these cases grafts such as autografts and
allografts must be used to bridge the long nerve gaps. Although
autografts are recognized as the gold standard for nerve grafting,
they have several limitations including limited donor source,
functional loss in the distribution of the donor nerve, scarring, and
painful neuroma formation [3–4]. Allografts also have defects in
limitations of source [5]. In order to find a means of reconstructing
injured nerves, peripheral nerve xenotransplantation has become
an increasingly promising alternative.
A significant barrier to xenotransplantation is the humoral and
cellular rejection that can occur which is mediated by antibodies,
T cells, and innate immune cells. Cellular immune responses that
play a critical role in nerve graft rejection [6–7], are likely to be
more important than humoral immune responses. For instance,
human T-cell responses against pig antigens are stronger than
against alloantigens in vitro, limiting dilution analyses [8]. A study
using a human complement regulatory protein (CD46)-transgenic
pig-to-baboon heart transplantation model, in which the recipients
were treated with a B-cell-depleting antibody and an a1,3-
galactosyltransferase (a1,3Gal) polymer to remove a1,3Gal-
specific antibodies, but not with anti-T-cell therapy, revealed an
important role for T cells, in particular, in xenograft rejection [9].
In our previous study using mouse peripheral nerve xenografts in a
rat model, we also demonstrated that a transient and moderate
increase in the production of Th1 cytokines, including IL-2, IFN-
c, and TNF-a occurs during rejection, but there were no
significant changes of Th2 cytokines after xenograft transplanta-
tion, such as IL-4 [6]. Therefore, Th1 cells and the cytokines they
produce, likely play an important role in rejection during mouse
peripheral nerve xenotransplantation.
Classically, effector CD4+ T cells have been assigned to the Th1
or Th2 lineage based on their cytokine profiles. Th1 cells evolved
to enhance clearance of intracellular pathogens, and are defined
on the basis of their production of IFN-c. Th2 cells are critical for
the control of certain parasitic infections through the production of
the clustered group of cytokines, IL-4, IL-5 and IL-13. The Th1/
Th2 paradigm has been used to identify the mechanisms of
different organ transplant rejections. The concept involves the
notion that the two subsets are cross-regulated. Thus, cytokines
released from cells of one subset have the ability to stimulate their
own subset in an autocrine fashion and, at the same time, inhibit
the other subset.
Recently, these two classical lineages have been joined by
additional subsets that preferentially produce distinct cytokines.
One such subset is called Th17, which selectively produces IL-17
[10–15]. Th17 cells are important for clearance of a variety of
pathogens [16], and are associated with numerous autoimmune
and inflammatory conditions. Th17 cells have also been
implicated in acute and chronic rejection in animal models of
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been thought to regulate one another, there is similar evidence
regarding the relationship between Th1 and Th17 cells. Lack of
one of these cytokines in vivo appears to promote a response
dominated by the other [14,21–24]. However, they are not always
functionally antagonistic, but may in fact collaborate to accom-
plish some effector functions [25–30].
The role of Th17 cells and IL-17 in peripheral nerve
xenotransplantation has not yet been defined. We therefore, again
used the rat to mouse model to investigate the biological
importance of Th17, and the relationship between Th1 and
Th17 cells in peripheral nerve xenotransplant rejection. We found
that the changes of IL-4 level had no significant difference in
xenograft recipients,which is consistent with our previous result
[6]. While the mononuclear cells which expressed IFN-c and IL-
17 infiltrated around the grafts and IFN-c and IL-17 producing
CD4+ and CD8+ T cells significantly increased during the acute
rejection process. Furthermore, the rejection was prevented after
the treatment of IL-17 and IFN-c neutralizing antibodies. These
data indicate that Th17 cells are also involved in the process of
peripheral nerve xenotransplant acute rejection, in addition to
classically described Th1 cells.
Materials and Methods
1. Animals
Adult male Sprague Dawley rats (weighing 190 g) and adult
male BALB/c mice were used as donor and recipients, respectively
(4 mice at least in each group). All animals were purchased from
Jilin University (Changchun, China). All surgical procedures and
postoperative care of the animals were approved by the
Institutional Animal Ethics Committee.
2. Peripheral Nerve Xenotransplantation
The rat sciatic nerve of the donor was exposed through a dorsal
gluteal muscle splitting incision, and a segment (0.5 cm) of sciatic
nerve was harvested and used immediately. The skin over the
mouse recipient right hindlimb was incised, the muscle was bluntly
dissected to expose the sciatic nerve, and a 0.5 cm gap was
created. The rat sciatic nerve graft was interposed to the
transected nerve and immediately repaired with 11-0 nylon
epineurial sutures. Mice in which the sciatic nerve was exposed
without xenotransplantation, were used as the sham control group.
Eight mice (4 from the xenotransplant group and 4 from the sham
control group) were sacrificed at each time point (Day 1, 3, 6, 11,
16, and 30).
3. IFN-c and IL-17 neutralization in vivo
4 ug IFN-c neutralizing antibody and 4 ug IL-17 neutraliz-
ing antibody (eBioscience, San Diego, USA) were injected
respectively into peritoneal cavity of mice one day before
xenotransplantation.
4. Histological Evaluation
Nerve grafts and the surrounding muscle and adipose tissues
from sacrificed animals were fixed in 10% (v/v) neutral buffered
formalin, and embedded in paraffin and sectioned. The 4-mm
sections were stained with hematoxylin and eosin (H&E) for
histological examination. The degree of mononuclear cells
infiltration were scored in the section using a 2006 objective
and scored as follows: 1=minimal, 2=mild, 3=moderate,
4=severe pathology. This scale contains 0–100, 100–300, 300–
600 and .600 cells respectively.
5. Immunohistochemical Staining
Anti-mouse IFN-c antibody (XMG1.2, Westang Biotechnology,
Shanghai, China), anti-mouse IL-17 antibody (Tc11-18h10,
Westang Biotechnology, Shanghai, China), anti-mouse IL-4
antibody (BVD4-1D11, Westang Biotechnology, Shanghai, China)
and rabbit IgG (Westang Biotechnology, Shanghai, China) were
used for immunohistochemical staining of the nerve grafts. Four
sections, which included the grafts and surrounding tissues, were
stained for each sample, and three sections were randomly chosen
to be stained with IFN-c, IL-17 and IL-4. Tissue sections were cut
from paraffin-embedded tissue blocks and placed onto slides. After
deparaffinization, sections were soaked in target retrieval buffered
saline (TRS, pH 6.1, Dako Cytomation, Carpinteria, CA) in a
plastic pressure cooker containing no metals, and irradiated in a
microwave oven for 10 minutes (maximum 500 W). After
irradiation, sections were rinsed under running water for
2 minutes, soaked in 3% H2O2 methanol solution for 5 minutes,
and then soaked in 5% BSA for 1 minute. Primary antibodies
were diluted to a previously determined optimal concentration in
PBS containing 5% BSA. The diluted antibodies were applied to
the tissue sections in a humid chamber and irradiated intermit-
tently for 10 minutes (250W, 4 seconds-on, 3 seconds-off). After 3
washes with Tris-buffered saline containing 1% Tween (TBS-T)
for 1 minute, the peroxidase-conjugated Envision kit reagents for
mouse (Westang Biotechnology, Shanghai, China) were applied to
the appropriate specimens in the humid chamber. Irradiation was
then performed intermittently for 10 minutes, as described above.
After washing 56 with TBS-T, the sections were immersed in
DAB solution (Sigma-Aldrich) with H2O2 and counterstained with
Hematoxylin (Dako Cytomation) and mounted under coverslips.
The degree of IFN-c+, IL-17+, and IL-4+ cellular infiltration were
scored in the section using a 2006objective and scored as follows:
1=minimal, 2=mild, 3=moderate, 4=severe pathology. This
scale contains 0–15, 15–50, 50–100, and .100 positive cells
respectively.
6. Enzyme-linked Immunosorbent Assay (ELISA)
Whole blood was collected and allowed to clot at room
temperature for 20 minutes. The clots were removed by
centrifuging at 15006g for 10 minutes in a refrigerated centrifuge.
The levels of cytokines in the serum supernatant were measured by
ELISA assay using commercially available IFN-c, IL-17 and IL-4
ELISA kits (Westang Biotechnology, Shanghai, China) according
to the manufacturer’s instructions.
7. Flow Cytometric Analysis of Intracellular Cytokine
Staining (ICS)
Whole spleens were homogenized in PBS, and the cell
suspension was filtered to remove debris. The cells were collected
by centrifugation at 15006g for 10 minutes in a refrigerated
centrifuge. The cells were then washed and resuspended with
FACS buffer. After processing, 1–2610
6 cells/mL were stimulated
with phorbol 12-myristate 13-acetate (PMA; Sigma Chemical Co.,
St. Louis, MO) (50 ng/mL) plus 2 mg/ml of ionomycin for
6 hours. Brefeldin A (10 mg/ml) was added 2 hours before the
cells were collected and stained with antibodies. The cells were
stained with antibodies against surface markers (anti-mouse CD3
and CD8, eBioscience, San Diego, USA). Cells were then
permeabilized and fixed using fixing (Caltag, Burlingame, USA)
and membrane permeabilizing (Caltag, Burlingame,USA)
reagents according to the manufacturer’s instructions, followed
by incubation with anti-IL-17-FITC (eBioscience, San Diego,
USA), anti-IL-4-FITC (eBioscience, San Diego, USA), anti-
Rejection of Peripheral Nerve Xenotransplant
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e34419IFN-c-PE (eBioscience), or isotope-matched control antibodies
for 30 minutes. Flow cytometry (FACSCalibur
TM, Beckton
Dickinson) was performed and data were analyzed using FlowJo
software.
8. Statistical Analysis
The difference between the means of the groups was
determined by the student’s t test for parametric data sets. All
statistical analyses were performed using Prism 4 (GraphPad
Software, San Diego, CA). A p value #.05 was considered
statistically significant in all analyses herein.
Results
1. Mononuclear cell infiltration surrounding the grafts
In order to examine the general cellular changes around the
grafts during rejection, the tissue was collected, sectioned and
visualized using routine H&E staining. Compared to the control
group, we observed that xenograft adhesion to the surrounding
tissue was progressively overwhelmed in all mice during the 30-day
observation period in all grafted animals. Histologic evidence of
rejection was identified in all grafted tissue samples. There was no
significant difference during 30 days after xenotransplantation in
control group. The level of mononuclear cell infiltration,
distension, and necrosis significantly increased in all xenografts
at different time point after xenotransplantation compared with
the control group. (Fig. 1).
2. IFN-c, IL-17 and IL-4 immunoreactivity around the
grafts
In order to determine whether the mononuclear cells surround-
ing the xenografts expressed IFN-c, IL-17, and IL-4, we next
performed immunohistochemical staining. We found that scat-
tered immunoreactivity for IFN-c, IL-17 and IL-4 can be detected
in the infiltrating mononuclear cells in the recipients animals
compared to the sham controls. Evenmore, IFN-c+ cells and IL-
17+ cells significantly increased in the xenografts recipients
between day 6 and day 30. In contrast, no significant changes of
IL-4+ cells in the tissues surrounding the xenograft have been
dectected. (Fig. 2).
Figure 1. H&E staining of nerve grafts. Sham control or xenotransplanted sciatic nerve from mice was collected at 1, 3, 6, 11, 16, and 30 days
posttransplantation, sectioned, and stained with H&E. Staining demonstrated xenograft adhesion to the surrounding tissue, and infiltration of
mononuclear cells into the peripheral nerve and surrounding tissue. There was no significant difference during 30 days after xenotransplantation in
control group. The level of mononuclear cell infiltration, distension, and necrosis significantly increased in all xenografts at all time point after
transplantation compared with control group. Magnification: 2006. (We performed animal experiment twice, and stained 2 sections for each animal.)
doi:10.1371/journal.pone.0034419.g001
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during acute rejection
To provide a more quantitative assessment of changes in
IFN-c and IL-17 during rejection, concentrations of both
cytokines were quantified by ELISA from sera of xenograft and
sham control animals. The sera levels of IFN-c and IL-17 at day 1,
3, and 6 were statistically higher in the xenograft recipients
compared to the control group. The levels of both cytokines
returned to control values by day 11 after transplantation. The IL-
4 levels in sera did not show significant changes between the
recipients with xenograft transplantation and the control group
(Fig. 3).
4. IFN-c and IL-17 expression in spleen lymphocytes
transiently increased during acute rejection
In order to better characterize the cellular identity of the IFN-c,
IL-17 and IL-4 expressing cells, spleens were collected from the
mice at each time point and used for flow cytometry to validate
expression of IFN-c, IL-17 and IL-4 in lymphocytes after
transplantation (Fig. 4A). IFN-c and IL-17 double producers from
CD3+ cells were fewer than single producers, and there was no
significant difference between experimental and control group
after xenotransplantation (data not show). We found that IFN-c
producing CD3+CD8+ T cells and IL-17 producing CD3+CD8+
T cells significantly increased after transplantation. Similar to the
changes observed in sera, there were no differences between the
sham control and xenotransplant groups after day 11 (Fig. 4B–C).
IFN-c producing CD3+CD82 T cells significantly increased from
day 1 which lasted to day 6, but IL-17 producing CD3+CD82 T
cells demonstrated a delay and increased from day 3 which lasted
to day 6. The percentage of IFN-c producing CD3+CD82 T cells
and IL-17 producing CD3+CD82 T cells demonstrated no
differences between the xenotransplant group and sham control
group after day 11 (Fig. 4B–C). There are no significant changes of
IL-4 producing CD3+CD82T cells and IL-4 producing
CD3+CD8+T cells between xenografts recipients and sham
controls. (Fig. 4B–C)
Figure 2. Immunohistochemical staining of nerve grafts. (A) Immunohistochemical staining of collected nerve grafts from sham control and
xenotransplanted mice, were immunostained using anti-IFN-c, anti-IL-17, and anti-IL-4 antibodies with DAB as the chromogen with a Hematoxylin
counterstain. Both antibodies demonstrated scattered immunoreactivity in the infiltrating mononuclear cells. Representative images are shown.
Magnification: 2006. (B) IFN-c+ cells and IL-17+ cells increased in xenotransplanted group from day 6 to day 30 compared to the sham controls. There
is no significant difference of IL-4+ cells between the recipients and control group. *, p,0.05; **, p,0.01; *** p,0.001. (We performed experiment
twice, and stained 2 sections for IFN-c and IL-17 respectively of each animal.)
doi:10.1371/journal.pone.0034419.g002
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significantly alleviated after using IL-17 and IFN-c
neutralizing antibodies
In order to investigate the role of IFN-c and IL-17 in peripheral
nerve xenotransplantation, we blocked IFN-c or (and) IL-17 by
using neutralizing antibodies before transplantation of rat nerve
into the mice. The sera levels of IFN-c and IL-17 at day 6 were
statistically lower in the xenograft recipients with IFN-c and IL-17
neutralizing antibodies single and mixed used compared with the
recipients without antibodies. The levels of both cytokines
returned to values of recipients without antibodies by day 11
after transplantation. There was no significant difference between
the groups of antibody single used and mixed used. At the same
time, we set up another experiment by injection of the neutralizing
antibodies one day after xenotransplantation in which we got the
consistent outcome that the animals injected the neutralizing
antibody before xenotransplantation (Information S1). The levels
of IFN-c producing CD3+CD8+ T cells and IL-17 producing
CD3+CD8+ T cells decreased at day 3 and day 6, IFN-c
producing CD3+CD82 T cells, and IL-17 producing
CD3+CD82 T cells decreased at day 3 in the recipients with
IL-17 neutralizing antibody and mixed used antibodies compared
to the levels of recipients without antibodies. Although the level of
IFN-c and IL-17 was lower in the group with mixed used
antibodies than the group of IL-17 antibody single used, there was
no significant difference between these two groups (Fig. 5A). We
observed scattered immunoreactivity for both IFN-c and IL-17 in
the infiltrating mononuclear cells, and found that mononuclear
cells invasion decreased at day 3 and day 6; IFN-c and IL-17
expression decreased in the recipients with IFN-c and IL-17
neutralizing antibodies single used and mixed used from day 11
after transplantation (Fig. 5B).
Discussion
Nerve injuries causing a segmental loss require nerve grafting.
However, this procedure often does not provide satisfactory results
[31]. The use of revascularized cutaneous nerve autografts,
allografts, or artificial nerve grafts may offer a solution to nerve
segmental loss as a conduit for nerve regeneration. However, all of
these strategies contain problems that limit their clinical use [32].
Based on these limitations, nerve xenografts provide a readily
accessible alternative strategy. Compared to autografts and
allografts, xenografts can induce stronger rejection. However,
the peripheral nerve has decreased antigenicity compared to skin,
tendon, and some other organs, suggesting it is useful for
continued study as a tissue source for nerve grafts. The
mechanisms of peripheral nerve xenograft rejection remain
complicated and unclear. For instance, the role of Th17 and
any regulatory mechanisms among different Th cell subsets during
xenograft rejection are unknown. We observed dynamic temporal
changes in cellular expression of IFN-c, IL-17 and IL-4 during
acute rejection after peripheral nerve xenotransplantation. The
critical findings of this study demonstrate that mononuclear cells
significantly infiltrate in and around the nerve grafts and these cells
can express either IFN-c or IL-17. This expression also increases
in serum and spleen during acute rejection of these peripheral
nerve xenotransplants. IFN-c and IL-17 significantly decreased in
sera and tissue surrounding the xenografts after IFN-c and IL-17
neutralizing antibodies treatment Also we found that IFN-c and
IL-17 decreased in spleen after using IL-17 neutralizing antibody
and using mixed antibodies. It appeared that both CD4+ and
CD8+ T cells were involved in the rejection process and Th17
along with Th1 cells may contribute to the development of acute
rejection in mice with peripheral nerve xenotransplant.
It has been demonstrated that cellular immunity, especially T
cells, plays a vital role during organ xenotransplant rejection [8–
9,33–34]. In addition to direct killing activity by cytotoxic T
lymphocytes, xenograft rejection can occur through T-cell-
mediated mechanisms, including cytokine production, recruitment
and activation of other cytotoxic cells, as well as by providing help
for B cells that produce xenoreactive antibodies [35]. T
lymphocytes are activated after contact with APCs presenting
antigens expressed by Schwann cells, and produce a set of
cytokines including IFN-c, IL-2, IL-4, and IL-6. Our demonstra-
tion of increased IFN-c expression in this study correlates well with
prior work indicating that cellular immune responses and Th1
cells play a critical role in nerve xenograft rejection. Although IL-4
producing CD3+CD82T cells and IL-4 producing CD3+CD8+T
cells decreased at day 1 and day3, and increased from day6 in the
xenografts recipients compared to the controls, there is no
significant difference between these two groups, which suggested
Figure 3. ELISA assays of IFN-c, IL-17 and IL-4 in serum. Sera from collected blood at each time point (1, 3, 6, 11, 16, and 30 days) from
xenotransplanted and sham control mice were used for ELISA analysis. Sera IFN-c and IL-17 levels in the xenograft group were significantly higher
than those in the serum in the control group (p,0.05) at day 1, day 3 and day 6, and decreased to control levels by day 11. There is no significant
difference of IL-4 levels between recipients and control group. *, p,0.05; **, p,0.01; *** p,0.001. (We performed this experiment twice).
doi:10.1371/journal.pone.0034419.g003
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nerve xenotransplantation and the changes of Th2 cells might be
due to the changes of Th1 cells.
The implication that following transplantation, CD8+ T cells
can mount an effective immune response independently of help
from CD4+ T cells, has recently gained support from studies of
CD8+ T cell responses to pathogens [36–39]. Kreisel et al.
reported that mouse non-hematopoietic cells activated alloreactive
CD8+ T lymphocytes in vitro and in vivo [40]. The CD8+IL-17-
producing T cell subpopulation is also important for effector
functions during the elicitation of contact hypersensitivity [41].
CD8+IL-17-producing T cells are stimulated by IL-23 but
inhibited by IL-12, implicating that different mechanisms regulate
the development and function of CD8+ IFN-c T cells and
CD8+IL-17 T cells [41]. Our data indicated that IFN-c and IL-17
produced by CD8+ T cells increased in the spleen from day 1 to
day 6 post xenotransplantation. This implies that CD8+ IFN-c T
cells and CD8+IL-17 T cells both played a role during peripheral
nerve acute rejection. However, the regulatory mechanisms
between these two cell populations needs to be further studied.
Th17 cells expressing retinoic acid-related orphan receptor
ct(RORct) play a crucial role in the development of autoimmunity
and transplant rejection, by producing pro-inflammatory cytokines
IL-17, and to a lesser extent, IL-23 and IL-6 [42]. Some studies
have demonstrated that Th17 and IL-17 contribute to rejection
during heart, lung, liver, and other organ allotransplantation
[12,20,43–45]. The role of Th17 and IL-17 in xenotransplantation
rejection remains unknown. However, our findings demonstrated
that serum levels of IL-17 and spleen levels of CD3+CD82 IL-17-
producing cells increased in mice during acute rejection after
peripheral nerve xenotransplantation. Furthermore, we found that
IL-17 levels increased in tissue surrounding the xenografts, which
might confirm that production of secreted IL-17 was enhanced not
only systematically, but locally as well. IL-17 producing T cells
Figure 4. Flow cytometry analysis of IFN-c, IL-17 and IL-4 in lymphocytes from spleen. Spleens were collected at each time point from
xenotransplanted mice (day 1, 3, 6, 11, 16, and 30) and sham controls, and used for flow cytometry analysis (A) Representative data of IFN-c, IL-17 and
IL-4 expression in lymphocytes from spleen at day 1. Graph a, b, c and d are gated from R1; e, f, g, and h are gated from R2. (B) Percentage of
CD3+CD82 T cells expressing IFN-c, IL-17 and IL-4 at days 1–30 were averaged and graphed. IFN-c expression increased from day 1 to day 6, and
decreased to control levels by day 11. IL-17 expression increased at day 3 and lasted until day 6, and decreased to control levels by day 11. There is no
significant difference of IL-4 producing CD3+CD82T cells between recipients and control group. *, p,0.05; **, p,0.01; *** p,0.001. (C) In CD3+CD8+
T cells, IFN-c and IL-17 expression increased from day 1 to day 6, and decreased to control levels by day 11. There is no significant difference of IL-4
producing CD3+CD8+T cells between recipients and control group. *, p,0.05; **, p,0.01; *** p,0.001. (We performed this experiment twice).
doi:10.1371/journal.pone.0034419.g004
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e34419significantly decreased in serum, spleen and tissues surrounding
the xenografts after single and mixed using IFN-c and IL-17
neutralizing antibody. These results suggest that Th17 cells, as well
as Th1 cells, play a key role in the pathophysiology of nerve
xenograft rejection.
There are controversial conclusions regarding the relationship
between Th1 and Th17 cells. For instance, a lack of one of these
cytokines in vivo appears to promote a response dominated by the
other. IFN-c-deficient mice develop an elevated Th17 response
and exacerbated disease [14,23–24]. Conversely, IL-17 deficiency
may permit emergence of Th1 as an effector response [23]. Other
findings underscore the role of the tissue in affecting the site where
inflammation occurs, and provide evidence that Th1 and Th17
cells are not always functionally antagonistic, but may in fact
collaborate to accomplish some effector functions [25–26]. It has
become clear that the relationship between the Th1 and Th17
lineages is much more intertwined and complex than was initially
appreciated, although there is little data describing any relation-
ship between Th1 and Th17 cells during xenotransplant rejection.
Based upon the results from this study, we propose that IFN-c and
IL-17 producing CD3+CD82 cells do not precisely function in
parallel during acute rejection. Spleen CD3+CD82 Th1 cells
increased from day 1 to day 6, and appeared earlier than the
increase in CD3+CD82 Th17 cells from day 3 to day 6. Although
spleen and sera changes in xenotransplanted animals returned to
control levels by day 11 posttransplant there was a temporal
inconsistency between sera and spleen for IL-17. One possibility
for this difference could be the fact that IL-17 expressing cells
differ between spleen and blood. For example, increased
expression of IL-17 by neutrophils, macrophages, or other innate
immune cells in blood could explain the increase in sera by day 1
post-xenotransplant whereas the spleen levels of IL-17 are a
reflection of primarily lymphocyte expression. Another possibility
is that sera concentrations of IL-17 were contributed to primarily
by CD3+CD8+ cells in the spleen as these increased by day 1. Any
regulatory relationships between Th1 cells and Th17 cells during
acute rejection as well as the identity of all immune cells secreting
IL-17 requires further study.
Our data demonstrates that both IFN-c and IL-17 producing
CD4+ and CD8+ T cells increase in a temporal fashion during
acute nerve xenograft rejection. The rejection significantly
decreased after single and mixed using IL-17 and IFN-c
neutralizing antibodies. This suggests that not only Th1 cells,
but also Th17 cells contribute to the process of rejection. A better
understanding of the ways in which Th1 and Th17 cellular
responses interact, is essential for understanding disease patho-
genesis and for determining appropriate therapeutic methods for
organ xenotransplantation. Further studies may provide new
targets for preventing xenograft rejection and promoting regen-
eration of nerve xenografts.
Supporting Information
Information S1 A.Sera from collected blood at each time point
(1, 3, 6, 11, 16, and 30 days) from xenotransplanted mice with
IFN-c and IL-17 neutralizing antibody single and mixed used
were used for ELISA analysis. The sera levels of IFN-c and IL-17
at day 6 were statistically lower in the xenograft recipients with
IFN-c and IL-17 neutralizing antibodies single and mixed used
compared with the recipients without antibodies. The levels of
both cytokines returned to values of recipients without antibodies
by day 11 after transplantation. B. We performed single and mixed
antibody injection at Day 1 after xenotransplantation. Sera from
collected blood at each time point (3, 6, 11, 16, and 30 days) from
xenotransplanted mice were used for ELISA analysis. There was
no significant difference of sera levels of IFN-c and IL-17 between
the groups injected antibody before xenotransplantation and after
xenotransplantation. *, p,0.05; **, p,0.01; *** p,0.001. (We
performed this experiment twice).
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